MiR-19 is part of the oncogenic miR-17∼92 cluster [21], [22] and has been shown to be crucial for the oncogenic properties of this cluster in a murine Myc-driven B-cell lymphoma model [19], [23]. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.